Carson Wealth (CWM LLC)
INDP icon

Carson Wealth (CWM LLC)’s Indaptus Therapeutics INDP Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio INDP Stock Details INDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4 Buy
+2
New +$4 ﹤0.01% 5656

Other funds holding INDP

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return

Carson Wealth (CWM LLC)'s INDP Position: Q1 2026 in Review

Carson Wealth (CWM LLC) opened a new position in Indaptus Therapeutics (INDP) in Q1 2026: 2 shares worth $4. The stake represents ﹤0.01% of the portfolio and ranks #5656 among its holdings.

6 funds tracked by Wall St. Rank hold INDP as of Q1 2026.

  • Carson Wealth (CWM LLC) held 2 shares of Indaptus Therapeutics worth $4 as of Q1 2026.
  • Indaptus Therapeutics was a new Carson Wealth (CWM LLC) position in Q1 2026.
  • Indaptus Therapeutics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #5656 holding.
  • 6 funds tracked by Wall St. Rank held Indaptus Therapeutics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.